Gates Foundation Strategic Investment Fund Logo
Share this page:

Portfolio

Our investments accelerate growth and stimulate private sector innovation and investment, giving our partners additional tools to effect change and improve lives. We make investments that align with foundation issue areas from vaccine development to education in the United States.

More on the types of investments we make.

Here you can explore our current and past investments, filtered by issue area or investment type.

Achaogen Logo

Achaogen

Achaogen is focused on R&D and commercialization of antibacterials to combat multi-drug resistant, Gram-negative infections. The foundation’s investment is supporting the development of Achaogen’s monoclonal antibody (“mAb”) discovery platform.

Press Release
acrobatiq logo

Acrobatiq

The foundation invested in Acrobatiq, a leader in adaptive learning solutions, to support the growth of a next-generation adaptive learning, courseware, and analytics program.

Press Release
Affinivax Logo

Affinivax

Affinivax achieves unprecedented levels of immune response and disease protection by streamlining the process of vaccine design and allowing for multiple antigens to be effectively incorporated in a single vaccine.

News Story

Africa Health Fund

The foundation invested in the Africa Health Fund to provide capital to support new approaches to improving the quality and accessibility of private healthcare across the continent.

African Agricultural Capital Fund

The African Agricultural Capital Fund provides growth capital to companies that boost the productivity and profitability of smallholder farmers in East Africa.

Press Release
AgBiome Logos

AgBiome

AgBiome is focused on discovery and development of biological and transgenic products for crop protection. AgBiome identifies microbes from a wide variety of sources to harness their natural abilities to help crops resist pests and stresses.

Press Release
AgTech Logo

AgTech Accelerator

The Agtech Accelerator is a start-up incubator based in Research Triangle Park, NC focused on fostering entrepreneurship in agriculture, supported by a syndicate of investors, including ARCH Venture Partners, Flagship Ventures, Hatteras Venture Partners, Bayer CropScience, Syngenta Ventures, and others.

Press Release
amyris logo

Amyris

The foundation invested in Amyris to support the development of new, low-cost technologies for manufacturing compounds to make semi-synthetic artemisinin that can be used in anti-malaria treatments.

Anacor Logo

Anacor Pharmaceuticals

Anacor Pharmaceuticals developed and commercialized novel therapeutics with its boron chemistry platform. The foundation partnered with the team to support development of preclinical drug candidates.

Press Release
Case Study
News Story
Arsanis Logo

Arsanis

Arsanis is focused on discovery and development of novel monoclonal antibodies (“mAbs”) to prevent and treat infectious disease. The foundation is working with Arsanis to develop a prophylactic mAb candidate targeting Stap aureus, a leading cause of neonatal sepsis which leads to approximately 345,000 annual deaths globally.

Press Release
News Story